BABACAN, T. Et Al. 2015. Chemotherapy might not be beneficial in lymph node-negative, hormone-positive, and HER2-negative breast cancer patients: a long-term retrospective analysis. JOURNAL OF BUON , vol.20, no.2 , 479-486.

BABACAN, T., Buyukhatipoglu, H., Balakan, O., KERTMEN, N., Suner, A., Sarici, F., ... AKIN, S.(2015). Chemotherapy might not be beneficial in lymph node-negative, hormone-positive, and HER2-negative breast cancer patients: a long-term retrospective analysis. JOURNAL OF BUON , vol.20, no.2, 479-486.

BABACAN, TANER Et Al. "Chemotherapy might not be beneficial in lymph node-negative, hormone-positive, and HER2-negative breast cancer patients: a long-term retrospective analysis," JOURNAL OF BUON , vol.20, no.2, 479-486, 2015

BABACAN, TANER Et Al. "Chemotherapy might not be beneficial in lymph node-negative, hormone-positive, and HER2-negative breast cancer patients: a long-term retrospective analysis." JOURNAL OF BUON , vol.20, no.2, pp.479-486, 2015

BABACAN, T. Et Al. (2015) . "Chemotherapy might not be beneficial in lymph node-negative, hormone-positive, and HER2-negative breast cancer patients: a long-term retrospective analysis." JOURNAL OF BUON , vol.20, no.2, pp.479-486.

@article{article, author={TANER BABACAN Et Al. }, title={Chemotherapy might not be beneficial in lymph node-negative, hormone-positive, and HER2-negative breast cancer patients: a long-term retrospective analysis}, journal={JOURNAL OF BUON}, year=2015, pages={479-486} }